AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 215 filers reported holding AMICUS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $132,181,716 | 10.68% |
| Perceptive Advisors | 27,662,917 | $347,446,237 | 10.06% |
| Redmile Group, LLC | 19,566,961 | $245,761,030 | 9.43% |
| Finepoint Capital LP | 1,325,775 | $16,651,734 | 5.76% |
| CM Management, LLC | 450,000 | $5,652 | 5.51% |
| Avoro Capital Advisors LLC | 27,400,000 | $344,144,000 | 4.67% |
| Novo Holdings A/S | 2,095,900 | $26,324,504 | 2.03% |
| Artal Group S.A. | 4,562,567 | $57,306 | 1.78% |
| GREAT POINT PARTNERS LLC | 701,392 | $8,809,484 | 1.72% |
| SECTORAL ASSET MANAGEMENT INC | 729,924 | $9,167,845 | 1.53% |
| Boxer Capital, LLC | 2,325,000 | $29,202 | 1.35% |
| MPM BioImpact LLC | 516,139 | $6,482,706 | 1.30% |
| AlphaCentric Advisors LLC | 132,500 | $1,664,200 | 0.92% |
| Faithward Advisors, LLC | 278,661 | $3,739,632 | 0.86% |
| Ghost Tree Capital, LLC | 200,000 | $2,512,000 | 0.83% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,048,663 | $13,171,201 | 0.75% |
| SevenOneSeven Capital Management | 22,344 | $299,857 | 0.67% |
| Integral Health Asset Management, LLC | 387,000 | $4,860,720 | 0.60% |
| Orbimed Advisors | 1,856,400 | $23,316,384 | 0.42% |
| HighVista Strategies LLC | 62,581 | $786,017 | 0.36% |
External links
This page lists AMICUS THERAPEUTICS INC's shareholders in Q2 2023. To view AMICUS THERAPEUTICS INC's shareholder history, click here.